Susan Nzenze to Vaccines, Conjugate
This is a "connection" page, showing publications Susan Nzenze has written about Vaccines, Conjugate.
Connection Strength
0,651
-
Imputing the Direct and Indirect Effectiveness of Childhood Pneumococcal Conjugate Vaccine Against Invasive Pneumococcal Disease by Surveying Temporal Changes in Nasopharyngeal Pneumococcal Colonization. Am J Epidemiol. 2017 Aug 15; 186(4):435-444.
Score: 0,132
-
Assessing the impact of pneumococcal conjugate vaccines on invasive pneumococcal disease using polymerase chain reaction-based surveillance: an experience from South Africa. BMC Infect Dis. 2015 Oct 26; 15:450.
Score: 0,117
-
Effectiveness of pneumococcal conjugate vaccine against presumed bacterial pneumonia hospitalisation in HIV-uninfected South African children: a case-control study. Thorax. 2015 Dec; 70(12):1149-55.
Score: 0,114
-
Temporal association of infant immunisation with pneumococcal conjugate vaccine on the ecology of Streptococcus pneumoniae, Haemophilus influenzae and Staphylococcus aureus nasopharyngeal colonisation in a rural South African community. Vaccine. 2014 Sep 22; 32(42):5520-30.
Score: 0,107
-
Geographical migration and fitness dynamics of Streptococcus pneumoniae. Nature. 2024 Jul; 631(8020):386-392.
Score: 0,053
-
Streptococcus pneumoniae and other bacterial nasopharyngeal colonization seven years post-introduction of 13-valent pneumococcal conjugate vaccine in South African children. Int J Infect Dis. 2023 Sep; 134:45-52.
Score: 0,049
-
Population genomics of pneumococcal carriage in South Africa following the introduction of the 13-valent pneumococcal conjugate vaccine (PCV13) immunization. Microb Genom. 2022 06; 8(6).
Score: 0,046
-
Pneumococcal conjugate vaccines and hospitalization of children for pneumonia: a time-series analysis, South Africa, 2006-2014. Bull World Health Organ. 2017 Sep 01; 95(9):618-628.
Score: 0,033